Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1998;29:1656-1665

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iida, M.
Right arrow Articles by Traystman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iida, M.
Right arrow Articles by Traystman, R. J.

(Stroke. 1998;29:1656-1665.)
© 1998 American Heart Association, Inc.


Original Contributions

Mechanisms Underlying Cerebrovascular Effects of Cigarette Smoking in Rats In Vivo

Mami Iida, MD; Hiroki Iida, MD; Shuji Dohi, MD; Motoyasu Takenaka, MD; Hisayoshi Fujiwara, MD

From the Department of Anesthesiology and Critical Care Medicine and The 2nd Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.

Correspondence to Hiroki Iida, MD, Department of Anesthesiology and Critical Care Medicine, Gifu University School of Medicine, 40 Tsukasamachi, Gifu-City, Gifu 500-8705, Japan. E-mail address iida{at}cc.gifu-u.ac.jp

Background and Purpose—The effects of acute smoking on cerebral circulation are controversial. This study was designed (1) to clarify any differences between the effects of cigarette smoking and nicotine infusion and between the effects of single- and multiple-cigarette smoking on cerebral vessels and (2) to probe the mechanism(s) underlying the vascular responses.

Methods—In pentobarbital-anesthetized, mechanically ventilated Sprague-Dawley rats, pial vessel diameters were measured with the use of a cranial window preparation. We studied the effects of (1) 60 puffs per minute of mainstream cigarette smoke from cigarettes having 2 nicotine levels (0.1 and 1 mg per cigarette), (2) administration of nicotine (0.05 mg per body IV), and (3) repeated smoking (four 1 mg nicotine–containing cigarettes at 30-minute intervals) (n=6 each).

Results—Inhalation of smoke from a 0.1 or 1 mg nicotine–containing cigarette for 1 minute caused pial arterioles to constrict at 30 seconds (7.2% and 7.3%, respectively) and then to dilate (peak at 5 to 10 minutes; 4.6% and 17.9%, respectively). Nicotine infusion caused pial vasodilation (35.7%) without an initial vasoconstriction. Repeated smoking suppressed the pial vasodilation but not the initial vasoconstriction. The vasodilation induced by a single cigarette was greatly inhibited by pretreatment with mecamylamine or glibenclamide and attenuated by propranolol or N{omega}-nitro-L-arginine methyl ester; the initial vasoconstriction was inhibited by seratrodast, a thromboxane A2 receptor antagonist (n=6 in each case).

Conclusions—Single-cigarette smoking had a significant biphasic effect on cerebral arteriolar tone. The vasodilation was attenuated by repeated smoking. The vasodilation is most likely an effect of nicotine, at least in part mediated via sympathetic activation, NO production, and K+ channel activation. The vasoconstriction is partially due to thromboxane A2 induced by cigarette smoke.

Editorial Comment

Richard J. Traystman, PhD, Guest Editor

Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland




This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
H. Iida, M. Iida, M. Takenaka, N. Fukuoka, and S. Dohi
Rho-kinase inhibitor and Nicotinamide Adenine Dinucleotide PHosphate oxidase inhibitor prevent impairment of endothelium-dependent cerebral vasodilation by acute cigarette smoking in rats
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 89 - 94.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
K. Murphy, V. Dixon, K. LaGrave, J. Kaufman, R. Risinger, A. Bloom, and H. Garavan
A Validation of Event-Related fMRI Comparisons Between Users of Cocaine, Nicotine, or Cannabis and Control Subjects
Am J Psychiatry, July 1, 2006; 163(7): 1245 - 1251.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Singhal, S. Bevan, T. Barrick, P. Rich, and H. S. Markus
The influence of genetic and cardiovascular risk factors on the CADASIL phenotype
Brain, September 1, 2004; 127(9): 2031 - 2038.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Fang, H. Sun, and W. G. Mayhan
Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H528 - H534.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. Gerzanich, F. Zhang, G. A. West, and J. M. Simard
Chronic Nicotine Alters NO Signaling of Ca2+ Channels in Cerebral Arterioles
Circ. Res., February 16, 2001; 88(3): 359 - 365.
[Abstract] [Full Text] [PDF]